Ultraviolet Blood Irradiation (UBI)

Ultraviolet Blood Irradiation was once a widely utilized adjuvant treatment during the 1940s and 1950s, offering promise in addressing various health conditions. However, the emergence of antibiotics led to a decline in its usage as antibiotics became the primary treatment approach for infectious diseases. Despite its effectiveness, UBI gradually faded into obscurity as pharmaceutical interventions gained dominance in mainstream medicine.

In recent years, there has been a resurgence of interest in UBI, driven by several factors. One significant factor is the growing concern over antibiotic-resistant infections.

The UBI Procedure: The UBI procedure itself is relatively straightforward and minimally invasive. It involves inserting a small catheter into a vein in the forearm, similar to the process of donating blood. A small volume of blood, typically around 200 cc or 6 ounces, is then withdrawn from the body using sterile techniques. This blood is then passed through a flat quartz cuvette, where it is irradiated with ultraviolet light in a closed, sterile circuit. After undergoing irradiation, the blood is returned to the bloodstream through the same catheter. The entire procedure typically lasts about one hour.

Therapeutic Effects: The therapeutic effects of UBI are believed to be multifaceted, contributing to its potential efficacy in treating a wide range of health conditions. One key benefit is the enhancement of the immune system, which plays a crucial role in defending the body against infections and promoting overall health. UBI has been shown to increase oxygen absorption into body tissues, which can help improve cellular function and support immune function. Additionally, the irradiation of blood with ultraviolet light may help to destroy fungal, viral, and bacterial pathogens, providing antimicrobial benefits.